Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +

Gustave Roussy, Cancer Campus, Grand Paris185 enrolled

Overview

To study the correlation between the polymorphism of the main immunity genes and progression-free survival in ALCL of the child.

Study Type

INTERVENTIONAL

Allocation

Purpose

BASIC_SCIENCE

Masking

NONE

Enrollment

185

Conditions

ALCL

Interventions

Blood sampleOTHER

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Every patients treated according to COPAD-IGR, HM 89,91 and 97 and ALCL99 protocols and included in related studies * Clinical data registered in SFCE database * Signed consent form Exclusion Criteria: * No ALK expression on tumour * No consent signed

Locations (1)

Gustave Roussy

Villejuif, Val De Marne, France

Outcomes

Primary Outcomes

Number of single nucleotide polymorphisms in main immunogenicity genes using VERACODE ILLUMINA technology

Time frame: up to 78 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.